Skip to content

Drug interactions

Ertugliflozin-sitagliptin + Lopinavir

Severity: Moderate

Ertugliflozin-sitagliptin and Lopinavir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Protease inhibitors such as lopinavir/ritonavir can cause insulin resistance and hyperglycemia, which may reduce the effectiveness of antidiabetic therapy. Glycemic control may worsen in patients with diabetes.

What this interaction means in plain words

Ertugliflozin-sitagliptin and Lopinavir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ertugliflozin-sitagliptin belongs to Endocrine; Lopinavir belongs to Anti Virals.

Evidence level: Moderate

Why it happens

Protease inhibitor associated insulin resistance and impaired glucose metabolism oppose the glucose-lowering drugs.

What to do

Monitor blood glucose and HbA1c after starting or changing the antiretroviral regimen, and intensify antidiabetic therapy if needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ertugliflozin-sitagliptin and Lopinavir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ertugliflozin-sitagliptin with Lopinavir?

MediHelp rates the interaction as moderate. Ertugliflozin-sitagliptin and Lopinavir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Protease inhibitors such as lopinavir/ritonavir can cause insulin resistance and hyperglycemia, which may reduce the effectiveness of antidiabetic therapy. Glycemic control may worsen in patients with diabetes.

How serious is the interaction between Ertugliflozin-sitagliptin and Lopinavir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose and HbA1c after starting or changing the antiretroviral regimen, and intensify antidiabetic therapy if needed.

What other medicines interact with Ertugliflozin-sitagliptin?

MediHelp also lists interactions of Ertugliflozin-sitagliptin with, for example, Albiglutide, Aripiprazole, Asenapine. The full list is on the Ertugliflozin-sitagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in